FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
177 products match “Recombi” (finished products)
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Recothromthrombin topical recombinant | — | Kit | Baxter Healthcare Corporation | 0338-0322 |
| Recothromthrombin topical recombinant | — | Kit | Baxter Healthcare Corporation | 0338-0326 |
| Recothromthrombin topical recombinant | — | Kit | Baxter Healthcare Corporation | 0338-0330 |
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-3026 |
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-3028 |
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. |
| 0944-3030 |
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-3032 |
|---|
| Rixubiscoagulation factor ix (recombinant) | — | Kit | Takeda Pharmaceuticals America, Inc. | 0944-3034 |
|---|
| Ruconestc1 esterase inhibitor recombinant | Conestat alfa 2100 U/1 | Injection, Powder, For solutionIntravenous | Pharming Healthcare Inc. | 71274-350 |
|---|
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 1600 mg/10mL; Hyaluronidase (Human recombinant) 20000 mg/10mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-510 |
|---|
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2240 mg/14mL; Hyaluronidase (Human recombinant) 28000 mg/14mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-514 |
|---|
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2400 mg/15mL; Hyaluronidase (Human recombinant) 30000 mg/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-515 |
|---|
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 3520 mg/22mL; Hyaluronidase (Human recombinant) 44000 mg/22mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-522 |
|---|
| Rylazeasparaginase erwinia chrysanthemi (recombinant)-rywn | Asparaginase 20 mg/mL | InjectionIntramuscular | Jazz Pharmaceuticals, Inc. | 68727-900 |
|---|
| Sevenfactcoagulation factor viia recombinant human | — | KitIntravenous | Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) | 71127-1000 |
|---|
| Sevenfactcoagulation factor viia recombinant human | — | KitIntravenous | Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) | 71127-2000 |
|---|
| Sevenfactcoagulation factor viia recombinant human | — | KitIntravenous | Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.) | 71127-5000 |
|---|
| Shingrixzoster vaccine recombinant, adjuvanted | Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL | Injection, SolutionIntramuscular | A-S Medication Solutions | 50090-7919 |
|---|
| Shingrixzoster vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-823 |
|---|
| Shingrixzoster vaccine recombinant, adjuvanted | Recombinant varicella zoster virus glycoprotein e antigen 50 ug/.5mL | Injection, SolutionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-849 |
|---|